SCHEMBL2910562

SCHEMBL2910562

COc1c(NC(=O)c2ccc(NS(C)(=O)=O)cc2)cc(N2C(=O)CCNC2=O)cc1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.41
MAPK10 P53779 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CRBN Q96SW2 1/20 0.39
ADRB1 P08588 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.38
F10 P00742 2/20 0.37
MAPK14 Q16539 1/20 0.37
MAPK1 P28482 1/20 0.36
CYP3A4 P08684 2/20 0.36
NAMPT P43490 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915428 0.89 RAB9A (0.40) HPGDMAPK10SMN1; SMN2RAB9ANPC1
SCHEMBL2916517 0.89 MEN1 (0.41) CRBNMEN1KMT2AALDH1A1MAPT
SCHEMBL2912681 0.88 CRBN (0.38) HPGDSMN1; SMN2RAB9ANPC1CRBN
SCHEMBL2908369 0.87 MAPT (0.37) HPGDSMN1; SMN2RAB9ANPC1NPSR1
SCHEMBL2910630 0.87 MEN1 (0.46) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL2915916 0.85 CRBN (0.39) HPGDSMN1; SMN2RAB9ANPC1NPSR1
SCHEMBL2915057 0.84 CRBN (0.39) SMN1; SMN2RAB9ANPC1CRBNMEN1
SCHEMBL2915218 0.84 CYP3A4 (0.40) CRBNADRB1CYP3A4
SCHEMBL3107879 0.84 MAPT (0.52) HPGDSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL2907766 0.84 KMT2A (0.41) SMN1; SMN2RAB9ANPC1CRBNMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed